Recent genome-wide association studies with human T2D patients have identified a genetic variant near the IRS1 gene associated with decreased IRS1 levels, increased T2D, insulin resistance and hyperinsulinemia [19]. The gene discussed is IRS1; the disease is hyperinsulinism.